NCT04067856View on ClinicalTrials.gov

Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Diabetic Macular EdemaCataract
Interventions
DRUG

Bevacizumab Injection

Intravitreal injection

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

collaborator

Doheny Image Reading Center

OTHER

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER